SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001583648-18-000074
Filing Date
2018-11-07
Accepted
2018-11-07 16:05:08
Documents
52
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q pirs9-30x201810xq.htm 10-Q 677798
2 EXHIBIT 31.1 exhibit311q3.htm EX-31.1 9791
3 EXHIBIT 31.2 exhibit312q3.htm EX-31.2 9610
4 EXHIBIT 32.1 exhibit321q3.htm EX-32.1 5681
5 EXHIBIT 32.2 exhibit322q3.htm EX-32.2 5553
  Complete submission text file 0001583648-18-000074.txt   3342486

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT pirs-20180930.xml EX-101.INS 584210
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pirs-20180930.xsd EX-101.SCH 31962
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pirs-20180930_cal.xml EX-101.CAL 49681
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pirs-20180930_def.xml EX-101.DEF 108509
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pirs-20180930_lab.xml EX-101.LAB 365546
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pirs-20180930_pre.xml EX-101.PRE 202364
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37471 | Film No.: 181166265
SIC: 8731 Services-Commercial Physical & Biological Research
Assistant Director 9